PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17307376-8 2007 RESULTS: GH treatment decreased hepatic triglyceride content and increased hepatic triglyceride secretion rate and serum cholesterol levels. Cholesterol 121-132 growth hormone Mus musculus 9-11 25152388-8 2014 On the contrary, GH increased levels of glucose, cholesterol and leptin in plasma, and p-mTOR or p-p38 in livers, and decreased plasma adiponectin and hepatic IR beta-subunit compared to saline treatment. Cholesterol 49-60 growth hormone Mus musculus 17-19 11387232-0 2001 Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice. Cholesterol 30-41 growth hormone Mus musculus 0-14 11387232-1 2001 Growth hormone (GH) has pleiotropic effects on cholesterol and lipoprotein metabolism. Cholesterol 47-58 growth hormone Mus musculus 0-14 11387232-1 2001 Growth hormone (GH) has pleiotropic effects on cholesterol and lipoprotein metabolism. Cholesterol 47-58 growth hormone Mus musculus 16-18 11387232-2 2001 Pituitary GH is important for the normal regulation of hepatic LDL receptors (LDLR), for the enzymatic activity of bile acid regulatory cholesterol 7alpha-hydroxylase (C7alphaOH), and for the maintenance of resistance to dietary cholesterol. Cholesterol 136-147 growth hormone Mus musculus 10-12 11387232-5 2001 In LDLR mice, GH infusion reduced plasma cholesterol and triglycerides up to 40%, whereas HMG CoA reductase and C7alphaOH activities were stimulated by approximately 50% and 110% respectively. Cholesterol 41-52 growth hormone Mus musculus 14-16 30130150-0 2018 IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1. Cholesterol 16-27 growth hormone Mus musculus 57-71